675 related articles for article (PubMed ID: 28500629)
1. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
[TBL] [Abstract][Full Text] [Related]
2. The relationship between gestational age and the severity of neonatal abstinence syndrome.
Gibson KS; Stark S; Kumar D; Bailit JL
Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
[TBL] [Abstract][Full Text] [Related]
3. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
[TBL] [Abstract][Full Text] [Related]
4. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
[TBL] [Abstract][Full Text] [Related]
5. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
[TBL] [Abstract][Full Text] [Related]
6. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
[TBL] [Abstract][Full Text] [Related]
7. Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure.
Faherty LJ; Matone M; Passarella M; Lorch S
Matern Child Health J; 2018 Jun; 22(6):841-848. PubMed ID: 29417369
[TBL] [Abstract][Full Text] [Related]
8. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital.
Newman A; Davies GA; Dow K; Holmes B; Macdonald J; McKnight S; Newton L
Can Fam Physician; 2015 Dec; 61(12):e555-61. PubMed ID: 27035006
[TBL] [Abstract][Full Text] [Related]
9. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
McQueen KA; Murphy-Oikonen J; Desaulniers L
Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
[TBL] [Abstract][Full Text] [Related]
10. Neonatal abstinence syndrome: Historical perspective, current focus, future directions.
Jones HE; Fielder A
Prev Med; 2015 Nov; 80():12-7. PubMed ID: 26232620
[TBL] [Abstract][Full Text] [Related]
11. Gender and NAS: does sex matter?
Holbrook A; Kaltenbach K
Drug Alcohol Depend; 2010 Nov; 112(1-2):156-9. PubMed ID: 20576365
[TBL] [Abstract][Full Text] [Related]
12. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.
Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM
Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326
[TBL] [Abstract][Full Text] [Related]
13. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.
Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT
BMJ; 2015 May; 350():h2102. PubMed ID: 25975601
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in utero drug exposure to substances of abuse*.
Bhatt-Mehta V; Ng CM; Schumacher RE
Pediatr Crit Care Med; 2014 Feb; 15(2):162-9. PubMed ID: 24141658
[TBL] [Abstract][Full Text] [Related]
15. Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine.
O'Connor AB; Kelly BK; O'Brien LM
Drug Alcohol Depend; 2017 Nov; 180():200-203. PubMed ID: 28917206
[TBL] [Abstract][Full Text] [Related]
16. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants.
McQueen KA; Murphy-Oikonen J; Gerlach K; Montelpare W
Adv Neonatal Care; 2011 Aug; 11(4):282-90. PubMed ID: 22123351
[TBL] [Abstract][Full Text] [Related]
17. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic management of the opioid neonatal abstinence syndrome.
Kraft WK; van den Anker JN
Pediatr Clin North Am; 2012 Oct; 59(5):1147-65. PubMed ID: 23036249
[TBL] [Abstract][Full Text] [Related]
19. Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA.
Gomez Pomar E; Finnegan LP; Devlin L; Bada H; Concina VA; Ibonia KT; Westgate PM
BMJ Open; 2017 Sep; 7(9):e016176. PubMed ID: 28963285
[TBL] [Abstract][Full Text] [Related]
20. A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.
Hall ES; Isemann BT; Wexelblatt SL; Meinzen-Derr J; Wiles JR; Harvey S; Akinbi HT
J Pediatr; 2016 Mar; 170():39-44.e1. PubMed ID: 26703873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
